Nkure Therapeutics
PrivateLast Round
Pre Seed
Apr 26, 2023
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nkure Therapeutics is a biotechnology company developing affordable natural killer (NK) cell-based immunotherapies for cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nkure Therapeutics Comparables
Compare Nkure Therapeutics with similar companies based on industry and business-model similarity.
Nkure Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 26, 2023 |
Nkure Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Endiya Partners | Pre Seed |
| Kotak Mahindra Trustee | Pre Seed |
| Innovative Quest Private Limited | Pre Seed |
| Kotak Alternate Asset Managers | Pre Seed |
| Department of Biotechnology | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Aug 21, 2026
Monthly visitors grew 470% MoM to 1.2K.
Recent news
Latest coverage and updates
- receives_financingAug 31, 2026
NKure Therapeutics Pvt. Ltd. receives financing of $2.15M.
Nkure Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nkure Therapeutics's valuation, stock price, and market status.
Is Nkure Therapeutics a public or private company?
Nkure Therapeutics is a private company.
What is the current stock price of Nkure Therapeutics?
Nkure Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Nkure Therapeutics worth (valuation)?
Valuation information for Nkure Therapeutics is not publicly available.
Can I buy Nkure Therapeutics stock?
Nkure Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nkure Therapeutics's last funding round?
Nkure Therapeutics's most recent funding round was Seed on April 26, 2023.
Who are the main investors in Nkure Therapeutics?
Key investors in Nkure Therapeutics include Endiya Partners, Innovative Quest Private Limited, Kotak Alternate Asset Managers.
Will Nkure Therapeutics IPO soon?
No public IPO plans have been announced for Nkure Therapeutics.
How can I track Nkure Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nkure Therapeutics's secondary market activity and sign up for updates.